| 1 |
Alphanate - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 2 |
Benlysta (belimumab) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 3 |
Doptelet (avatrombopag) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 4 |
Epidiolex (cannabidiol) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 5 |
Esbriet (pirfenidone) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 6 |
Firdapse (amifampridine) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 7 |
Hemlibra (emicizumab-kxwh) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 8 |
Ibrance (palbociclib) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 9 |
Imbruvica (ibrutinib) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 10 |
KISQALI Drug Insight and Market Forecast – 2032 |
Report Link
|
| 11 |
Lumizyme (alglucosidase alfa) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 12 |
Luxturna (voretigene neparvovec-rzyl) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 13 |
Nexavar (sorafenib) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 14 |
Nplate (romiplostim)Romiplate - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 15 |
Ofev (nintedanib) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 16 |
Prevymis (letermovir) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 17 |
Promacta/Revolade (eltrombopag) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 18 |
Rhopressa (netarsudil ophthalmic solution) - Drug Insight and Market Forecast - 2032 |
Report Link
|
| 19 |
ROCKLATAN Drug Insight and Market Forecast – 2032 |
Report Link
|
| 20 |
Rozlytrek (entrectinib) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 21 |
Ruzurgi (amifampridine) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 22 |
Xadago (safinamide) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 23 |
Spinraza (nusinersen) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 24 |
Sutent (sunitinib malate) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 25 |
VERZENIO Drug Insight and Market Forecast – 2032 |
Report Link
|
| 26 |
Vonvendi [von Willebrand factor (recombinant)] (US)/VEYVONDI [vonicog alfa, a recombinant human von Willebrand factor (rVWF)] (EU) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 27 |
Vyzulta (latanoprostene bunod ophthalmic solution) - Drug Insight and Market Forecast - 2032 |
Report Link
|
| 28 |
Xifaxan (rifaximin) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 29 |
Zolgensma (onasemnogene abeparvovec-xioi) - Drug Insight and Market Forecast - 2030 |
Report Link
|
| 30 |
CAP-1002 - Emerging Insight and Market Forecast - 2030 |
Report Link
|
| 31 |
Gemcabene - Emerging Insight and Market Forecast - 2030 |
Report Link
|
| 32 |
Edasalonexent - Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 33 |
Casimersen - Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 34 |
Ganaxolone - Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 35 |
Givinostat - Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 36 |
Idebenone - Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 37 |
PF-06939926 - Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 38 |
Inclisiran - Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 39 |
SAGE-217 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 40 |
SRP-9001 - Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 41 |
Vamorolone - Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 42 |
NS-065/NCNP-01 (Viltolarsen) - Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 43 |
AAV2/8 LSPHGAA - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 44 |
ACE-536 (Luspatercept)- Drug Insight and Market Forecast – 2030 |
Report Link
|
| 45 |
AT845 - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 46 |
AVR RD 01 - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 47 |
DNX-2401 (Tasadenoturev) - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 48 |
FLT190 - Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 49 |
Lenti-D- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 50 |
RT 100 - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 51 |
SPK 3006 - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 52 |
ST-920 - Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 53 |
VB 111 (VBL Therapeutics)- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 54 |
Zynteglo- Drug Insight and Market Forecast – 2030 |
Report Link
|
| 55 |
177-LUTETIUM-PSMA-617- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 56 |
BERCOLAGENE TELSERPAVEC (KB103)- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 57 |
BLU 782- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 58 |
EB 101- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 59 |
FCX-007- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 60 |
GARETOSMAB (REGN2477)- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 61 |
HC 1119- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 62 |
HORA-PDE6B - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 63 |
KB 105 - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 64 |
Onvansertib + Abiraterone - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 65 |
PALOVAROTENE- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 66 |
Seviteronel- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 67 |
Talimogene Laherparepvec- Drug Insight and Market Forecast – 2030 |
Report Link
|
| 68 |
YSELTY (LINZAGOLIX; OBE2109) - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 69 |
VEBICORVIR (ABI-H0731)- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 70 |
Selgantolimod (GS-9688) - Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 71 |
RELUGOLIX (TAK-385) - Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 72 |
GSK3228836- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 73 |
Evobrutinib (M2951) - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 74 |
Tenofovir disoproxil- Drug Insight and Market Forecast – 2030 |
Report Link
|
| 75 |
Tenofovir alafenamide- Drug Insight and Market Forecast – 2030 |
Report Link
|
| 76 |
Orilissa (Elagolix)- Drug Insight and Market Forecast – 2030 |
Report Link
|
| 77 |
Mavyret- Drug Insight and Market Forecast – 2030 |
Report Link
|
| 78 |
Harvoni- Drug Insight and Market Forecast – 2030 |
Report Link
|
| 79 |
Epclusa- Drug Insight and Market Forecast – 2030 |
Report Link
|
| 80 |
Entecavir- Drug Insight and Market Forecast – 2030 |
Report Link
|
| 81 |
Otilimab (GSK3196165) - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 82 |
Olokizumab - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 83 |
Filgotinib - Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 84 |
Upadacitinib- Drug Insight and Market Forecast – 2030 |
Report Link
|
| 85 |
scAAV9.CB.CLN6- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 86 |
AAV RPGR- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 87 |
AAV9 CLN3- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 88 |
Blincyto - Drug Insight and Market Forecast – 2030 |
Report Link
|
| 89 |
DTX301- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 90 |
Elamipretide- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 91 |
Erleada - Drug Insight and Market Forecast – 2030 |
Report Link
|
| 92 |
GT005- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 93 |
HMR59- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 94 |
IONIS FB LRX- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 95 |
JCELL- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 96 |
Jevtana - Drug Insight and Market Forecast – 2030 |
Report Link
|
| 97 |
Kymriah - Drug Insight and Market Forecast – 2030 |
Report Link
|
| 98 |
Nubeqa - Drug Insight and Market Forecast – 2030 |
Report Link
|
| 99 |
Onpattro - Drug Insight and Market Forecast – 2030 |
Report Link
|
| 100 |
OpRegen- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 101 |
PEGCETACOPLAN (APL-2)- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 102 |
RGX-121- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 103 |
RO7171009 (RG6147)- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 104 |
SB-525- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 105 |
SB-913- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 106 |
Shingrix - Drug Insight and Market Forecast – 2030 |
Report Link
|
| 107 |
SPK-8011- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 108 |
Tagrisso - Drug Insight and Market Forecast – 2030 |
Report Link
|
| 109 |
Tepmetko - Drug Insight and Market Forecast – 2030 |
Report Link
|
| 110 |
Valrox (Valoctocogene Roxaparvovec)- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 111 |
Vyndaqel - Drug Insight and Market Forecast – 2030 |
Report Link
|
| 112 |
Xtandi - Drug Insight and Market Forecast – 2030 |
Report Link
|
| 113 |
Yescarta - Drug Insight and Market Forecast – 2030 |
Report Link
|
| 114 |
ZIMURA- Emerging Drug Insight and Market Forecast – 2030 |
Report Link
|
| 115 |
Zytiga - Drug Insight and Market Forecast – 2030 |
Report Link
|
| 116 |
UB-221- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 117 |
REZAFUNGIN- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 118 |
LY3454738 Drug Insight, Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 119 |
KPL-716 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 120 |
LOU064 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 121 |
FENEBRUTINIB- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 122 |
Ligelizumab Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 123 |
FOSMANOGEPIX- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 124 |
Dupilumab Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 125 |
IBREXAFUNGERP- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 126 |
Benralizumab Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 127 |
LUM001- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 128 |
ISATUXIMAB- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 129 |
A4250- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 130 |
DUR-928- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 131 |
EVOMELA- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 132 |
TADEKINIG ALFA- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 133 |
TOCILIZUMAB- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 134 |
Melflufen Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 135 |
Ilaris- Drug Insight and Market Forecast – 2030 |
Report Link
|
| 136 |
DARATUMUMAB- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 137 |
CERC-007- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 138 |
Elotuzumab Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 139 |
ANAKINRA- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 140 |
ADVM-022- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 141 |
BROLUCIZUMAB- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 142 |
GB-102- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 143 |
FARICIMAB- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 144 |
KVD001- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 145 |
VX-561- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 146 |
LUMINATE- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 147 |
PTI-801- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 148 |
PTI-808- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 149 |
IONIS ENAC 2.5- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 150 |
PTI-428- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 151 |
MRT5005- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 152 |
MEPOLIZUMAB- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 153 |
ENSIFENTRINE- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 154 |
ELX-02- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 155 |
ARO-ENAC- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 156 |
ELUFORSEN- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 157 |
AK002- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 158 |
VX 121- Emerging Insight and Market Forecast – 2030 |
Report Link
|
| 159 |
BIVV020 (SAR445088), Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 160 |
EMPAVELI/ASPAVELI Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 161 |
INCB050465 (Parsaclisib), Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 162 |
LNP023 (Iptacopan) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 163 |
Paclitaxel trevatide (ANG1005) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 164 |
NurOwn (MSC-NTF Cells), Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 165 |
TIGLUTIK, Drug Insight and Market Forecast – 2032 |
Report Link
|
| 166 |
Tezepelumab Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 167 |
EPI-589 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 168 |
MN-166 (Ibudilast) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 169 |
Pridopidine Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 170 |
DUPIXENT Drug Insight and Market Forecast – 2032 |
Report Link
|
| 171 |
Tofersen Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 172 |
Omburtamab Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 173 |
ANX005, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 174 |
ION363, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 175 |
Pegcetacoplan (APL-2), Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 176 |
FASENRA (Benralizumab) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 177 |
SPRAVATO Drug Insight and Market Forecast – 2032 |
Report Link
|
| 178 |
AXS-05 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 179 |
Esketamine DPI Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 180 |
MIJ821, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 181 |
REL-1017, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 182 |
VRAYLAR, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 183 |
EXSERVAN Drug Insight and Market Forecast – 2032 |
Report Link
|
| 184 |
AMX0035 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 185 |
AP-101 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 186 |
AT-1501 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 187 |
CNM-Au8 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 188 |
Masitinib Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 189 |
PrimeC Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 190 |
Reldesemtiv Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 191 |
RNS60 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 192 |
SLS-005 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 193 |
Verdiperstat Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 194 |
BNC210, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 195 |
JZP150, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 196 |
NYX-783, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 197 |
Rexulti and Zoloft Combination, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 198 |
XOLAIR Drug Insight and Market Forecast – 2032 |
Report Link
|
| 199 |
NUCALA Drug Insight and Market Forecast – 2032 |
Report Link
|
| 200 |
BESREMi Drug Insight and Market Forecast – 2032 |
Report Link
|
| 201 |
BOMEDEMSTAT Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 202 |
GIVINOSTAT Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 203 |
Itacitinib Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 204 |
JAKAFI Drug Insight and Market Forecast – 2032 |
Report Link
|
| 205 |
Rusfertide Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 206 |
Sapablursen Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 207 |
CONTRAVE (Naltrexon-Bupropion), Drug Insight and Market Forecast – 2032 |
Report Link
|
| 208 |
IMCIVREE (Setmelanotide), Drug Insight and Market Forecast – 2032 |
Report Link
|
| 209 |
QSYMIA (Phentermine– topiramate), Drug Insight and Market Forecast – 2032 |
Report Link
|
| 210 |
SAXENDA (Liraglutide), Drug Insight and Market Forecast – 2032 |
Report Link
|
| 211 |
Tirzepatide, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 212 |
WEGOVY (Semaglutide), Drug Insight and Market Forecast – 2032 |
Report Link
|
| 213 |
XENICAL (Orlistat), Drug Insight and Market Forecast – 2032 |
Report Link
|
| 214 |
EB05 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 215 |
Benralizumab Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 216 |
VRAYLAR Market Drug Insight and Market Forecast – 2032 |
Report Link
|
| 217 |
Ligelizumab Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 218 |
XOLAIR Marketed Drug Insight and Market Forecast − 2032 |
Report Link
|
| 219 |
NNC0174-0833 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 220 |
PF-06882961 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 221 |
Semaglutide oral Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 222 |
Sibutramine/Topiramate Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 223 |
CNSA-001 (PTC923) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 224 |
PALYNZIQ (Pegvaliase-pqpz) Drug Insight and Market Forecast – 2032 |
Report Link
|
| 225 |
SYNB1618, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 226 |
KRT-232 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 227 |
PPMX-T003 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 228 |
Uromune (MV140) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 229 |
GSK2140944 (Gepotidacin) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 230 |
Sulopenem Etzadroxil/Probenecid Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 231 |
ExoFlo Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 232 |
Lucinactant Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 233 |
MultiStem Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 234 |
CUTX-101 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 235 |
NULIBRY Drug Insight and Market Forecast − 2032 |
Report Link
|
| 236 |
COMP360 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 237 |
FABRAZYME, Drug Insight and Market Forecast – 2032 |
Report Link
|
| 238 |
GALAFOLD, Drug Insight and Market Forecast – 2032 |
Report Link
|
| 239 |
REPLAGAL, Drug Insight and Market Forecast – 2032 |
Report Link
|
| 240 |
Venglustat, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 241 |
HMI-102, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 242 |
LP-10 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 243 |
Viralym-M Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 244 |
DSUVIA Drug Insight and Market Forecast – 2032 |
Report Link
|
| 245 |
Exparel Drug Insight and Market Forecast – 2032 |
Report Link
|
| 246 |
Maxigesic IV Drug Insight and Market Forecast – 2032 |
Report Link
|
| 247 |
PENTHROX Drug Insight and Market Forecast – 2032 |
Report Link
|
| 248 |
ZYNRELEF Drug Insight and Market Forecast – 2032 |
Report Link
|
| 249 |
CAM2029 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 250 |
Cimdelirsen Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 251 |
Paltusotine Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 252 |
Cosentyx Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 253 |
Gazyva Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 254 |
SAPHNELO Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 255 |
VAY736 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 256 |
LUPKYNIS Market Drug Insight and Market Forecast – 2032 |
Report Link
|
| 257 |
HALNEURON Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 258 |
APP13007 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 259 |
CR-845 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 260 |
4D-310, Emerging Drug Insight and Market Forecast |
Report Link
|
| 261 |
PRX-102 (Pegunigalsidase alfa), Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 262 |
KUVAN (Sapropterin Hydrochloride), Drug Insight and Market Forecast – 2032 |
Report Link
|
| 263 |
CIMZIA (Certolizumab pegol) Drug Insight and Market Forecast – 2032 |
Report Link
|
| 264 |
ENTYVIO (Vedolizumab) Drug Insight and Market Forecast – 2032 |
Report Link
|
| 265 |
STELARA (Ustekinumab), Drug Insight and Market Forecast – 2032 |
Report Link
|
| 266 |
TYSABRI (Natalizumab), Drug Insight and Market Forecast – 2032 |
Report Link
|
| 267 |
AXS-12 (Reboxetine) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 268 |
FT218 (Sodium oxybate), Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 269 |
EPIDIOLEX Drug Insight and Market Forecast – 2032 |
Report Link
|
| 270 |
PALFORZIA Drug Insight and Market Forecast – 2032 |
Report Link
|
| 271 |
LYBALVI Market Drug Insight and Market Forecast – 2032 |
Report Link
|
| 272 |
XOLAIR Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 273 |
ADP101 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 274 |
CA002 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 275 |
CNP-201 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 276 |
INP20 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 277 |
VE416 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 278 |
Ampion Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 279 |
AMZ-001 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 280 |
CNTX-4975 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 281 |
HP-5000 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 282 |
INVOSSA Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 283 |
JOINTSTEM Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 284 |
Lorecivivint Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 285 |
ReNu Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 286 |
TLC599 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 287 |
WEGOVY Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 288 |
ZILOSUL Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 289 |
Rilzabrutinib Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 290 |
APPA Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 291 |
CARTISTEM Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 292 |
JOYCLU Market Drug Insight and Market Forecast – 2032 |
Report Link
|
| 293 |
Sprifermin Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 294 |
JTA-004 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 295 |
X0002 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 296 |
FINTEPLA Drug Insight and Market Forecast – 2032 |
Report Link
|
| 297 |
VOTUBIA Drug Insight and Market Forecast – 2032 |
Report Link
|
| 298 |
Carisbamate Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 299 |
EPX-100 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 300 |
NBI-921352 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 301 |
Soticlestat Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 302 |
STK-001 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 303 |
DE-130A (Latanoprost), Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 304 |
DURYSTA (Bimatoprost SR) Drug Insight and Market Forecast – 2032 |
Report Link
|
| 305 |
NCX-470, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 306 |
Sepetaprost, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 307 |
TC-002, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 308 |
Ecopipam, Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 309 |
LP352 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 310 |
NBI-827104 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 311 |
PRAX562 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 312 |
XEN496 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 313 |
RSLV-132 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 314 |
VAY736 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 315 |
VIB4920 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 316 |
ZEPOSIA (Ozanimod) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 317 |
JYSELECA Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 318 |
RHB -104 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 319 |
RINVOQ (Upadacitinib) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 320 |
SKYRIZI (Risankizumab) Drug Insight and Market Forecast – 2032 |
Report Link
|
| 321 |
HUMIRA (Adalimumab) Drug Insight and Market Forecast – 2032 |
Report Link
|
| 322 |
REMICADE (Infliximab) Drug Insight and Market Forecast – 2032 |
Report Link
|
| 323 |
ARO-APOC3 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 324 |
Epeleuton Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 325 |
INVELTYS Drug Insight and Market Forecast – 2032 |
Report Link
|
| 326 |
Olezarsen Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 327 |
Pegozafermin Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 328 |
VAXELIS Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 329 |
OHB-607 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 330 |
VELETRI Drug Insight and Market Forecast – 2032 |
Report Link
|
| 331 |
SB206 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 332 |
BBP-631 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 333 |
Crinecerfont Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 334 |
Tildacerfont Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 335 |
PRAX-114 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 336 |
ABV-1504 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 337 |
Lumateperone Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 338 |
DMX-200 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 339 |
Sparsentan Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 340 |
VX-147 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 341 |
XELPROS Drug Insight and Market Forecast – 2032 |
Report Link
|
| 342 |
DE-117 Drug Insight and Market Forecast – 2032 |
Report Link
|
| 343 |
K-232 Drug Insight and Market Forecast – 2032 |
Report Link
|
| 344 |
PDP-716 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 345 |
Psilocybin Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 346 |
TNX-1300 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 347 |
CFZ533 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 348 |
OXERVATE Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 349 |
Aprocitentan Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 350 |
CIN-107 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 351 |
IONIS-AGT-LRx Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 352 |
ALOFISEL Drug Insight and Market Forecast – 2032 |
Report Link
|
| 353 |
CS1 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 354 |
Brazikumab Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 355 |
GB002 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 356 |
Etrasimod Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 357 |
Mirikizumab Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 358 |
TREMFYA Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 359 |
MK5475 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 360 |
Orenitram Drug Insight and Market Forecast – 2032 |
Report Link
|
| 361 |
Aurora-GT Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 362 |
Treprostinil palmitil Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 363 |
SPRAVATO Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 364 |
AV-101 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 365 |
Zamicastat Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 366 |
L606 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 367 |
AXS-05 Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 368 |
Ralinepag Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 369 |
LY03005 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 370 |
Birtamimab Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 371 |
Rodatristat ethyl Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 372 |
MN-202 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 373 |
RT234 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 374 |
CAEL-101 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 375 |
REL-1017 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 376 |
Sotatercept Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 377 |
DS107 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 378 |
Resiniferatoxin Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 379 |
PH10 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 380 |
FB825 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 381 |
VRAYLAR (MDD) Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 382 |
ADEMPAS Drug Insight and Market Forecast – 2032 |
Report Link
|
| 383 |
Ambrisentan Drug Insight and Market Forecast – 2032 |
Report Link
|
| 384 |
OPSUMIT Drug Insight and Market Forecast – 2032 |
Report Link
|
| 385 |
Sildenafil Drug Insight and Market Forecast – 2032 |
Report Link
|
| 386 |
VP-102 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 387 |
Tadalafil Drug Insight and Market Forecast – 2032 |
Report Link
|
| 388 |
BIO-11006 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 389 |
TRACLEER Drug Insight and Market Forecast – 2032 |
Report Link
|
| 390 |
CHRONOCORT Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 391 |
Nyxol (Phentolamine Mesylate) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 392 |
VUITY Drug Insight and Market Forecast – 2032 |
Report Link
|
| 393 |
VT-1011 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 394 |
PresbiDrops (CSF-1) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 395 |
Nyxol + Pilocarpine Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 396 |
MicroLine (pilocarpine) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 397 |
LNZ100 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 398 |
JEMPERLI (dostarlimab) Drug Insight and Market Forecast – 2032 |
Report Link
|
| 399 |
KEYTRUDA (pembrolizumab) Drug Insight and Market Forecast – 2032 |
Report Link
|
| 400 |
Lenvatinib + pembrolizumab Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 401 |
MIN-102 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 402 |
TYVASO Drug Insight and Market Forecast – 2032 |
Report Link
|
| 403 |
Treprostinil sodium Drug Insight and Market Forecast – 2032 |
Report Link
|
| 404 |
Braftovi (encorafenib) + Erbitux (cetuximab) ± Mektovi (binimetinib) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 405 |
Eftilagimod alpha (IMP321) Emerging Drug Insight and Market Forecast – 2035 |
Report Link
|
| 406 |
Favezelimab (MK-4280) Emerging Drug Insight and Market Forecast – 2035 |
Report Link
|
| 407 |
Fianlimab (REGN3767) Emerging Drug Insight and Market Forecast – 2035 |
Report Link
|
| 408 |
FS118 Emerging Drug Insight and Market Forecast – 2035 |
Report Link
|
| 409 |
Opdualag (nivolumab and relatlimab) Drug Insight and Market Forecast – 2035 |
Report Link
|
| 410 |
RG6139 (RO7247669) Emerging Drug Insight and Market Forecast – 2035 |
Report Link
|
| 411 |
ARQ-151 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 412 |
B244 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 413 |
Difelikefalin Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 414 |
KY1005 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 415 |
Tradipitant Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 416 |
OLUMIANT Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 417 |
OPZELURA Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 418 |
XARACOLL Drug Insight and Market Forecast – 2032 |
Report Link
|
| 419 |
ENBREL Drug Insight and Market Forecast – 2032 |
Report Link
|
| 420 |
REMICADE Drug Insight and Market Forecast – 2032 |
Report Link
|
| 421 |
UX701 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 422 |
VTX-801 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 423 |
ALXN1840 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 424 |
ENTYVIO Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 425 |
JYSELECA Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 426 |
RINVOQ Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 427 |
SIMPONI Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 428 |
STELARA Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 429 |
XELJANZ Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 430 |
WAYLIVRA Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 431 |
AUSTEDO Drug Insight and Market Forecast – 2032 |
Report Link
|
| 432 |
PIQRAY Drug Insight and Market Forecast – 2032 |
Report Link
|
| 433 |
LYNPARZA Drug Insight and Market Forecast – 2032 |
Report Link
|
| 434 |
LY3484356 (Imlunestrant) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 435 |
Giredestrant Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 436 |
VX15 (pepinemab) Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 437 |
AMT-130 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 438 |
ANX005 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 439 |
Ingrezza Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 440 |
Pridopidine Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 441 |
SAGE-718 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 442 |
SOM3355 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 443 |
Crovalimab Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 444 |
Iptacopan Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 445 |
SOLIRIS Drug Insight and Market Forecast – 2032 |
Report Link
|
| 446 |
ULTOMIRIS Drug Insight and Market Forecast – 2032 |
Report Link
|
| 447 |
DEXTENZA Drug Insight and Market Forecast – 2032 |
Report Link
|
| 448 |
LOTEMAX SM Drug Insight and Market Forecast – 2032 |
Report Link
|
| 449 |
VVZ-149 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 450 |
HUMIRA Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 451 |
REMICADE Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 452 |
Elinzanetant Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 453 |
Fezolinetant Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 454 |
Estetrol Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 455 |
Nedosiran Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 456 |
OXLUMO Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 457 |
LATUDA Market Drug Insight and Market Forecast – 2032 |
Report Link
|
| 458 |
COMP 360 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 459 |
CAPLYTA (lumateperone) Market Drug Insight and Market Forecast – 2032 |
Report Link
|
| 460 |
PH94B Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 461 |
MM-120 Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 462 |
ANJESO Drug Insight and Market Forecast – 2032 |
Report Link
|
| 463 |
POSIMIR Drug Insight and Market Forecast – 2032 |
Report Link
|
| 464 |
CIMZIA Drug Insight and Market Forecast – 2032 |
Report Link
|
| 465 |
HUMIRA Drug Insight and Market Forecast – 2032 |
Report Link
|
| 466 |
ORENCIA Drug Insight and Market Forecast – 2032 |
Report Link
|
| 467 |
RITUXAN Drug Insight and Market Forecast – 2032 |
Report Link
|
| 468 |
SIMPONI Drug Insight and Market Forecast – 2032 |
Report Link
|
| 469 |
SHR0302 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 470 |
TREMFYA Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 471 |
Etrasimod Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 472 |
Mirikizumab Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 473 |
SKYRIZI Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 474 |
ZEPOSIA Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 475 |
Lomitapide Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 476 |
ACTEMRA Drug Insight and Market Forecast – 2032 |
Report Link
|
| 477 |
KEVZARA Drug Insight and Market Forecast – 2032 |
Report Link
|
| 478 |
XELJANZ Drug Insight and Market Forecast – 2032 |
Report Link
|
| 479 |
OLUMIANT Drug Insight and Market Forecast – 2032 |
Report Link
|
| 480 |
RINVOQ Drug Insight and Market Forecast – 2032 |
Report Link
|
| 481 |
SMYRAF Drug Insight and Market Forecast – 2032 |
Report Link
|
| 482 |
JYSELECA Drug Insight and Market Forecast – 2032 |
Report Link
|
| 483 |
EYLEA Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 484 |
LUCENTIS Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 485 |
AJM300 Market Drug Insight and Market Forecast − 2032 |
Report Link
|
| 486 |
BT-11 Emerging Drug Insight and Market Forecast − 2032 |
Report Link
|
| 487 |
Datopotamab deruxtecan Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 488 |
Elacestrant Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 489 |
Enobosarm Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
| 490 |
Lasofoxifene Emerging Drug Insight and Market Forecast – 2032 |
Report Link
|
